Colorectal cancer (CRC) is the third most common form of cancer and the second leading cause of cancer-related death in the western world and[@b1][@b2]. CRC is a leading cause of cancer-related deaths in the United States, and its lifetime risk in the United States is about 7%[@b1][@b3]. CRC is a common complex disease caused by the combination of genetic variants and environmental factors[@b1]. Genome-wide association studies (GWAS) are considered to be new and power approaches to detect the genetic variants of human complex diseases. Recently, GWAS have been performed and reported some novel CRC susceptibility single nucleotide polymorphisms (SNPs) with genome-wide significance (*P* \< 5.00E-08), and these SNPs have been repliciated by meta-anaysis methods[@b4][@b5][@b6][@b7][@b8][@b9][@b10][@b11][@b12][@b13].

In 2012, Loo *et al.* conducted a cis-expression quantitative trait loci (cis-eQTLs) analysis to investigate the possible regulatory functions of 19 CRC risk variants on the expression of neighboring genes (\<2 Mb up- or down-stream)[@b14]. They identified three variants including rs10795668, rs4444235 and rs9929218 to be significantly associated with expression levels of nearby genes[@b14]. In 2014, Closa *et al.* analyzed the association between 26 CRC SNPs and the expression of genes within a 2 Mb region (cis-eQTLs) using 47 healthy colonic mucosa tissues and 97 normal mucosa tissues adjacent to colon cancer, and 97 paired tumor tissues[@b15]. Using Bonferroni correction, they identified three significant cis-eQTLs including rs3802842 in 11q23.1 associated with the expression of C11orf53, COLCA1 and COLCA2; rs7136702 in 12q13.12 associated with the expression of DIP2B and rs5934683 in Xp22.3 associated with the expression of SHROOM2 and GPR143. Closa *et al.* also reported other SNPs including rs7130173 for 11q23.1 and rs61927768 for 12q13.12, which are in linkage disequilibrium (LD) with rs3802842 and rs7136702, and are more strongly associated with the expression of the identified genes and are better functional candidates. In 2014, Yao *et al.* select 25 CRC SNPs, and test the hypothesis that the CRC SNPs and/or correlated SNPs are in elements that regulate gene expression[@b3]. They identified 23 promoters, 28 enhancers, and 66 putative target genes of the risk-associated enhancers[@b3].

Evidence shows that most variants for common human diseases are not correlated with protein-coding changes, indicating that susceptibility variants in regulatory regions may contribute to disease phenotypes[@b16]. For CRC, most risk variants also reside outside the coding regions of genes[@b3][@b14][@b15]. Until now, as described above, comprehensive functional studies of CRC SNPs on nearby gene expression have been reported[@b3][@b14][@b15]. Evidence from the National Human Genome Research Institute (NHGRI) GWAS catalog shows that 85 CRC susceptibility variants, which reach suggestive association *P* \< 1.00E-05, have been identified until now[@b17][@b18]. However, the exact genetic mechanisms for these newly identified CRC susceptibility variants are still unclear now. In order to investigate the potential regulatory functions for 85 newly identified CRC susceptibility variants, we conducted a pathway analysis of these CRC susceptibility genes around these CRC susceptibility variants.

Results
=======

CRC susceptibility genes from ProxyGeneLD
-----------------------------------------

Using the ProxyGeneLD and the LD information from the HapMap phase II Europe (CEU), 74 of these 85 unique CRC susceptibility variants were included in HapMap, and were successfully mapped to the corresponding genes 53 unique CRC susceptibility genes ([Table 1](#t1){ref-type="table"}). However, another 11 SNPs including rs11196172, rs73376930, rs11255841, rs10849432, rs35509282, rs140355816, rs34245511, rs12412391, rs4849303, rs57046232 and rs7999699 are not found in HapMap.

CRC susceptibility genes for pathway analysis
---------------------------------------------

Using the nearest upstream and downstream gene method in NHGRI GWAS catalog, we got 106 unique CRC susceptibility gene IDs as described above. We compared these 106 genes with 53 unique CRC susceptibility genes from the ProxyGeneLD, and found 31 shared genes. In the end, we got 128 unique CRC susceptibility genes, which is the union of genes from both methods.

Pathway analysis preprocessing
------------------------------

In WebGestalt database, 120 of 128 genes were successfully mapped to 120 unique Entrez Gene IDs[@b19]. Other 8 genes were mapped to multiple Entrez Gene IDs or could not be mapped to any Entrez Gene ID. The following pathway analysis will be based upon the 120 unique gene IDs.

Pathway analysis using GO database
----------------------------------

Our pathway analysis in GO database showed that these 120 CRC susceptibility genes were significantly enriched in 40 biological processes, 1 molecular function and 3 cellular components with adjusted *P* \< 0.01. 17 of these 44 significant signals are regulatory pathways, such as regulation of epithelial to mesenchymal transition, negative regulation of Wnt receptor signaling pathway, regulation of pathway-restricted SMAD protein phosphorylation, positive regulation of nucleocytoplasmic transport, regulation of muscle organ development, positive regulation of intracellular protein transport. Interestingly, regulation of epithelial to mesenchymal transition (GO:0010717) is the most significant signal ([Table 2](#t2){ref-type="table"}). More detailed information including the gene IDs is described in [supplementary Table 1](#S1){ref-type="supplementary-material"}.

Discussion
==========

Until now, 85 CRC susceptibility variants with suggestive association *P* \< 1.00E-05 have been reported[@b17][@b18]. To investigate the underlying genetic pathways where these newly identified CRC susceptibility genes are significantly enriched, we conducted a functional annotation. Using two kinds of SNP to gene mapping methods including the nearest upstream and downstream gene method and the ProxyGeneLD, we got 128 unique CRC susceptibility genes. We then conducted a pathway analysis in GO database using the corresponding 128 genes. We identified 44 GO categories, 17 of which are regulatory pathways.

Here, we identified the regulation of epithelial to mesenchymal transition (GO:0010717) to be the most significant signal in all the 44 GO categories and the most signal in all the 17 regulatory pathways. It is reported that the epithelial-mesenchymal transition-like dedifferentiation of the tumor cells is a character of CRC invasion[@b20]. Several studies have reviewed the association between epithelial-mesenchymal transition and CRC progression[@b21][@b22][@b23]. Our results show that these newly identified CRC susceptibility SNPs or genes may regulate epithelial-mesenchymal transition.

The negative regulation of Wnt receptor signaling pathway (GO:0030178) is the third significant signal in all the 44 GO categories and the second significant signal in all the 17 regulatory pathways. Evidence shows that aberrant regulation of the Wnt/β-catenin signaling pathway can cause CRC[@b24]. It is reported that the loss-of-function mutations in *APC* gene are common in CRC, and can cause inappropriate activation of Wnt signaling[@b24]. Recently, several studies have reviewed the involvement of Wnt signalling in CRC development[@b25][@b26][@b27]. Masuda *et al.* reported Wnt signaling to be the potential therapeutic target by targeting TNIK in CRC[@b28]. Here, our results show that these newly identified CRC susceptibility SNPs or genes may regulate Wnt receptor signaling pathway.

The positive regulation of nucleocytoplasmic transport pathway (GO:0046824) is the 8^th^ significant signal in all the 44 GO categories and the 4^th^ significant signal in all the 17 regulatory pathways. Hill *et al.* reviewed the mechanisms and role of nucleocytoplasmic transport in cancer therapy[@b29]. Here, we identified the pathway-restricted SMAD protein phosphorylation (GO:0060389) and regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393) to be 5^th^ and 7^th^ significant association signals, respectively. Interestingly, evidence shows that protein phosphorylation is a post-translational modification central to cancer biology[@b30]. Protein phosphorylation affects most eukaryotic cellular processes and its deregulation is considered a hallmark of cancer[@b31].

We also found that these newly identified CRC susceptibility SNPs or genes may regulate five GO categories related with cell differentiation including regulation of fat cell differentiation (GO:0045598), mesenchymal cell differentiation (GO:0048762), regulation of striated muscle cell differentiation (GO:0051153), negative regulation of myoblast differentiation (GO:0045662), and cell morphogenesis involved in differentiation (GO:0000904). Evidence showed the involvement of differentiation in CRC. Breaking the balance between proliferation and differentiation in animal cells can cause cancer[@b32]. PPAR-γ is a nuclear receptor with a dominant regulatory role in differentiation of cells of the adipose lineage[@b33]. PPAR-γ can modulate the growth and differentiation of CRC cells[@b33]. Differentiated human CRC cells protect tumor-initiating cells from irinotecan[@b34]. The resistance of colorectal tumors to irinotecan requires the cooperative action of tumor-initiating ALDHhigh/ABCB1negative cells and their differentiated, drug-expelling, ALDHlow/ABCB1positive daughter cells[@b34]. The calcium activated chloride channel A1 (CLCA1) is a member of the calcium sensitive chloride conductance family of proteins and is expressed mainly in the colon[@b32]. Recent study shows that CLCA1 plays an important role in differentiation and proliferation of Caco-2 cells, which can regulate the transition from proliferation to differentiation in CRC and may be a potential diagnostic marker for CRC prognosis[@b32].

Take together, our findings suggest that most CRC susceptibility variants are located in the intron region of protein encoding genes and are not correlated with protein-coding changes. Most of these 120 CRC susceptibility genes are involved in kinds of regulatory pathways. Our results may provide further insight into the underlying genetic mechanisms for these newly identified CRC susceptibility variants.

Materials and Methods
=====================

CRC susceptibility variants
---------------------------

The CRC susceptibility variants were available from the NHGRI GWAS catalog, which collected the results of published GWAS in online database[@b18]. We selected 85 unique CRC susceptibility variants with *P* \< 1.00E-05 from the GWAS CRC, CRC (calcium intake interaction), and CRC (diet interaction).

Data preprocessing
------------------

In NHGRI GWAS catalog, these 85 unique CRC susceptibility variants were successfully mapped to 167 nearest upstream and downstream genes. We further analyzed these 167 genes and got 106 unique CRC susceptibility gene IDs. The detailed information was described in [Table 1](#t1){ref-type="table"}.

Mapping SNPs to genes using the ProxyGeneLD
-------------------------------------------

In addition to the nearest upstream and downstream gene method, we also used a Perl software named ProxyGeneLD. ProxyGeneLD can map these 85 SNPs to their corresponding genes using the linkage disequilibrium (LD) information from the HapMap genotyping data (HapMap phase II Europe (CEU), release 22)[@b35]. For more detailed algorithms, please refer to the original study[@b35].

CRC susceptibility genes
------------------------

Here, we map these 85 SNPs to their corresponding genes using both methods as described above. The final CRC susceptibility gene set is the union of genes from both methods.

Pathway analysis using WebGestalt
---------------------------------

We used the GO pathways in WebGestalt database for pathway analysis[@b19]. The hypergeometric test was used to detect the overrepresentation of differently expressed AD genes among all of the genes in a given pathway[@b19]. The reference gene list is the entire Entrez gene set. The minimum number of genes for a category is 3. The FDR test was used to correct for multiple testing. GO pathways with an adjusted *P* \< 0.05 are considered to be significantly associated with CRC.
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###### The main information for 85 CRC susceptibility variants.

  SNP            Pubmed ID   Disease/Trait             Gene              *P* value   OR or beta       95% CI
  ------------- ----------- --------------- --------------------------- ----------- ------------ -----------------
  rs4939827      18372901         CRC                  SMAD7             8.00E-28       1.2       \[1.16--1.24\]
  rs7014346      18372901         CRC              LOC101930033          9.00E-26       1.19      \[1.15--1.23\]
  rs174537       24836286         CRC                  MYRF              9.00E-21       1.16      \[1.12--1.19\]
  rs16892766     18372905         CRC             LINC00536-EIF3H        3.00E-18       1.27      \[1.20--1.34\]
  rs10795668     24836286         CRC           RNA5SP299-LINC00709      5.00E-15       1.15      \[1.11--1.19\]
  rs6983267      17618284         CRC           CCAT2, LOC101930033      1.00E-14       1.27      \[1.16--1.39\]
  rs647161       24836286         CRC                 C5orf66            2.00E-14       1.15      \[1.11--1.19\]
  rs6983267      24836286         CRC           CCAT2, LOC101930033      5.00E-14       1.14      \[1.10--1.18\]
  rs10795668     18372905         CRC           RNA5SP299-LINC00709      3.00E-13       1.12      \[1.10--1.16\]
  rs10505477     24737748         CRC              LOC101930033          8.00E-13       1.2           \[NR\]
  rs4939827      17934461         CRC                  SMAD7             1.00E-12       1.16      \[1.09--1.27\]
  rs11196172     24836286         CRC                 TCF7L2             1.00E-12       1.14      \[1.10--1.18\]
  rs2423279      24836286         CRC                SRSF10P2            3.00E-12       1.13      \[1.09--1.17\]
  rs73376930     24737748         CRC           GREM1, LOC100131315      1.00E-11       1.25          \[NR\]
  rs6983267      23266556         CRC           CCAT2, LOC101930033      1.00E-11       1.13      \[1.09--1.18\]
  rs10505477     17618283         CRC              LOC101930033          3.00E-11       1.17      \[1.12--1.23\]
  rs7229639      24448986         CRC                  SMAD7             3.00E-11       1.22      \[1.15--1.29\]
  rs2427308      24737748         CRC                 CABLES2            3.00E-11       1.24          \[NR\]
  rs1035209      24737748         CRC             NKX2-3-SLC25A28        5.00E-11       1.12      \[1.08--1.16\]
  rs6983267      18372905         CRC           CCAT2, LOC101930033      7.00E-11       1.24      \[1.17--1.33\]
  rs11255841     24737748         CRC           RNA5SP299-LINC00709      7.00E-11       1.19          \[NR\]
  rs1321311      22634755         CRC                   N/A              1.00E-10       1.1       \[1.07--1.13\]
  rs10774214     24836286         CRC              RPL18P9-CCND2         1.00E-10       1.14      \[1.09--1.18\]
  rs647161       23263487         CRC                 C5orf66            1.00E-10       1.11      \[1.08--1.15\]
  rs961253       19011631         CRC             FGFR3P3-CASC20         2.00E-10       1.12      \[1.08--1.16\]
  rs11169552     20972440         CRC               DIP2B-ATF1           2.00E-10       1.09      \[1.05--1.11\]
  rs4925386      20972440         CRC                  LAMA5             2.00E-10       1.08      \[1.05--1.10\]
  rs4939827      23266556         CRC                  SMAD7             2.00E-10       1.12      \[1.09--1.16\]
  rs3824999      22634755         CRC                  POLD3             4.00E-10       1.08      \[1.05--1.10\]
  rs647161       23263487         CRC                 C5orf66            4.00E-10       1.17      \[1.11--1.22\]
  rs10774214     23263487         CRC              RPL18P9-CCND2         5.00E-10       1.17      \[1.11--1.23\]
  rs3802842      18372901         CRC             COLCA2, COLCA1         6.00E-10       1.11      \[1.08--1.15\]
  rs10849432     24836286         CRC              LOC102723767          6.00E-10       1.14      \[1.09--1.18\]
  rs5934683      22634755         CRC             GPR143-SHROOM2         7.00E-10       1.07      \[1.04--1.10\]
  rs4444235      19011631         CRC            RPS3AP46-MIR5580        8.00E-10       1.11      \[1.08--1.15\]
  rs6691170      20972440         CRC             DUSP10-QRSL1P2         1.00E-09       1.06      \[1.03--1.09\]
  rs12241008     25105248         CRC                  VTI1A             1.00E-09       1.13      \[1.09--1.18\]
  rs6687758      20972440         CRC             DUSP10-QRSL1P2         2.00E-09       1.09      \[1.06--1.12\]
  rs10411210     19011631         CRC                  RHPN2             5.00E-09       1.15      \[1.10--1.20\]
  rs2423279      23263487         CRC                SRSF10P2            7.00E-09       1.1       \[1.06--1.14\]
  rs35509282     25023989         CRC            MTHFD2P4-TOMM22P4       8.00E-09       1.53      \[1.39--1.67\]
  rs7758229      21242260         CRC                 SLC22A3            8.00E-09       1.28      \[1.18--1.39\]
  rs6687758      24836286         CRC             DUSP10-QRSL1P2         9.00E-09       1.12      \[1.08--1.17\]
  rs4143094      24743840       CRC^b^                 GATA3             9.00E-09       1.17      \[1.11--1.23\]
  rs9929218      19011631         CRC                  CDH1              1.00E-08       1.1       \[1.06--1.12\]
  rs1800469      24836286         CRC               TGFB1, B9D2          1.00E-08       1.09      \[1.06--1.12\]
  rs4779584      21761138         CRC               SCG5-GREM1           2.00E-08       1.18      \[1.11--1.24\]
  rs704017       24836286         CRC                ZMIZ1-AS1           2.00E-08       1.1       \[1.06--1.13\]
  rs7229639      24836286         CRC                  SMAD7             2.00E-08       1.2       \[1.16--1.25\]
  rs140355816    24737748         CRC             LINC00536-EIF3H        2.00E-08       1.59          \[NR\]
  rs6983267      21242260         CRC           CCAT2, LOC101930033      2.00E-08       1.18      \[1.11--1.25\]
  rs10936599     20972440         CRC                  MYNN              3.00E-08       1.04      \[1.04--1.10\]
  rs12603526     24836286         CRC                   NXN              3.00E-08       1.1       \[1.06--1.14\]
  rs10774214     23263487         CRC              RPL18P9-CCND2         3.00E-08       1.09      \[1.06--1.13\]
  rs34245511     24737748         CRC                  LIMA1             3.00E-08       1.14          \[NR\]
  rs367615       23300701         CRC             KRT18P42-MAN2A1        4.00E-08       1.35      \[1.20--1.49\]
  rs11903757     23266556         CRC               NABP1-SDPR           4.00E-08       1.16      \[1.10--1.22\]
  rs6469656      24836286         CRC             LINC00536-EIF3H        5.00E-08       1.09      \[1.06--1.13\]
  rs3217810      23266556         CRC                  CCND2             6.00E-08       1.2       \[1.12--1.28\]
  rs4948317      24836286         CRC                  BICC1             7.00E-08       1.1       \[1.06--1.13\]
  rs13343954     24737748         CRC                  RHPN2             7.00E-08       1.18          \[NR\]
  rs10911251     23266556         CRC                  LAMC1             9.00E-08       1.09      \[1.06--1.13\]
  rs4939827      21761138         CRC                  SMAD7             1.00E-07       1.14      \[1.08--1.18\]
  rs2423279      23263487         CRC                SRSF10P2            2.00E-07       1.14      \[1.08--1.19\]
  rs3802842      24836286         CRC             COLCA2, COLCA1         3.00E-07       1.09      \[1.05--1.12\]
  rs3217901      23266556         CRC                  CCND2             3.00E-07       1.1       \[1.06--1.14\]
  rs13130787     23266556         CRC             ATOH1-HMGB3P15         3.00E-07       1.09      \[1.06--1.13\]
  rs16892766     21761138         CRC             LINC00536-EIF3H        4.00E-07       1.24      \[1.14--1.34\]
  rs3802842      21761138         CRC             COLCA2, COLCA1         4.00E-07       1.14      \[1.08--1.20\]
  rs3802842      23266556         CRC             COLCA2, COLCA1         4.00E-07       1.11      \[1.06--1.15\]
  rs59336        23266556         CRC                  TBX3              4.00E-07       1.09      \[1.06--1.13\]
  rs4779584      18372905         CRC               SCG5-GREM1           5.00E-07       1.23      \[1.14--1.34\]
  rs4779584      23266556         CRC               SCG5-GREM1           5.00E-07       1.12      \[1.08--1.19\]
  rs12412391     24836286         CRC         LOC101927324, LINC01475    7.00E-07       1.08      \[1.05--1.11\]
  rs1028166      25192705       CRC^a^                  N/A              7.00E-07       1.49      \[1.27--1.74\]
  rs2901879      24743840       CRC^b^          MEIS1-AS2-DNMT3AP1       7.00E-07       1.11      \[1.06--1.16\]
  rs1871438      24743840       CRC^b^            NPM1P5-ST8SIA2         8.00E-07       1.11      \[1.07--1.16\]
  rs1665650      23263487         CRC                 HSPA12A            9.00E-07       1.13      \[1.08--1.19\]
  rs4849303      24743840       CRC^b^                 ACOXL             1.00E-06       1.12      \[1.08--1.18\]
  rs4147045      24743840       CRC^b^           KRT18P63-RPL21P46       1.00E-06       1.2        \[1.11--1.3\]
  rs8180040      23350875         CRC              KLHL18-PTPN23         2.00E-06       1.28      \[1.15--1.41\]
  rs4939827      18372905         CRC                  SMAD7             2.00E-06       1.18      \[1.10--1.25\]
  rs39453        23300701         CRC              SNRPCP19-CYCS         2.00E-06       1.28      \[1.16--1.43\]
  rs6855885      25192705       CRC^a^                CCSER1             2.00E-06       1.11      \[1.06--1.16\]
  rs1933755      25192705       CRC^a^            TMEM200A-SMLR1         2.00E-06       1.19      \[1.11--1.28\]
  rs1370916      24743840       CRC^b^             MRPL42P4-TNS3         2.00E-06       1.11      \[1.06--1.15\]
  rs6989010      24743840       CRC^b^          LINC00681-KIAA1456       2.00E-06       1.64        \[1.33--2\]
  rs2593957      24743840       CRC^b^                 MORC1             2.00E-06       1.15       \[1.09--1.2\]
  rs12534701     24743840       CRC^b^                 DPP6              2.00E-06       1.17      \[1.09--1.24\]
  rs4855695      24743840       CRC^b^            MORC1-FLJ22763         2.00E-06       1.14      \[1.08--1.20\]
  rs12548021     23350875         CRC             DUSP4-RPL17P33         3.00E-06       1.28      \[1.155--1.42\]
  rs12309274     24836286         CRC                  WNK1              3.00E-06       1.11      \[1.06--1.16\]
  rs10411210     24836286         CRC                  RHPN2             3.00E-06       1.12      \[1.07--1.17\]
  rs17730929     23300701         CRC              RPS23P3-CENPC         3.00E-06       1.47      \[1.25--1.72\]
  rs10114408     23300701         CRC              MIR4291-BARX1         3.00E-06       1.37      \[1.20--1.56\]
  rs4591517      23300701         CRC             SALL4P5-RPL24P7        3.00E-06       1.06      \[0.88--1.29\]
  rs10879357     23300701         CRC                  TPH2              3.00E-06       1.25      \[1.14--1.39\]
  rs57046232     24737748         CRC             FGFR3P3-CASC20         3.00E-06       1.11          \[NR\]
  rs2057314      23266556         CRC                 DCBLD1             3.00E-06       1.08      \[1.04--1.11\]
  rs17094983     23266556         CRC              DACT1-RPL31P4         3.00E-06       1.13      \[1.08--1.20\]
  rs7999699      24743840       CRC^b^            RPL27AP8-SUCLA2        3.00E-06       1.32      \[1.18--1.47\]
  rs3104964      23350875         CRC        LOC100616530, C8orf37-AS1   4.00E-06       1.27      \[1.14--1.40\]
  rs9365723      23300701         CRC                  SYNJ2             4.00E-06       1.27      \[1.15--1.41\]
  rs11671104     24743840       CRC^b^            GOLGA2P9-ZNF492        4.00E-06       1.25      \[1.13--1.37\]
  rs10752881     24836286         CRC             KRT18P28-LAMC1         5.00E-06       1.07      \[1.04--1.10\]
  rs7248888      24743840       CRC^b^                PNMAL1             5.00E-06       1.37      \[1.19--1.56\]
  rs7315438      21761138         CRC              TBX3-UBA52P7          6.00E-06       1.11      \[1.06--1.15\]
  rs4813802      23266556         CRC               CASC20-BMP2          7.00E-06       1.1       \[1.05--1.14\]
  rs2128382      23266556         CRC              GSDMC-FAM49B          8.00E-06       1.11      \[1.06--1.16\]
  rs1912453      23266556         CRC                C1orf110            9.00E-06       1.07      \[1.04--1.11\]

CRC, colorectal cancer; CRC^a^, CRC (calcium intake interaction); CRC^b^, CRC (diet interaction); OR, odds ratio; CI, confidence interval; Chr, Chromosome; NR, not reported.

###### Significant GO pathways from pathway analysis of 128 CRC susceptibility genes.

  GO categories             ID      Name                                                                                          C     O      E       R       rawP       adjP
  -------------------- ------------ ------------------------------------------------------------------------------------------- ------ ---- ------- ------- ---------- ----------
  biological process    GO:0010717  regulation of epithelial to mesenchymal transition                                            38    5    0.17    28.73   7.73E-07   8.55E-05
  biological process    GO:0060675  ureteric bud morphogenesis                                                                    68    6    0.31    19.27   6.43E-07   8.55E-05
  biological process    GO:0030178  negative regulation of Wnt receptor signaling pathway                                        112    7    0.51    13.65   7.60E-07   8.55E-05
  biological process    GO:0035295  tube development                                                                             436    12     2     6.01    5.73E-07   8.55E-05
  biological process    GO:0060389  pathway-restricted SMAD protein phosphorylation                                               37    5    0.17    29.51   6.74E-07   8.55E-05
  biological process    GO:0001657  ureteric bud development                                                                     104    7    0.48    14.7    4.59E-07   8.55E-05
  biological process    GO:0060393  regulation of pathway-restricted SMAD protein phosphorylation                                 33    5    0.15    33.08   3.72E-07   8.55E-05
  biological process    GO:0046824  positive regulation of nucleocytoplasmic transport                                            73    6    0.33    17.95   9.82E-07   9.50E-05
  biological process    GO:0048468  cell development                                                                             1461   21   6.69    3.14    1.20E-06   1.00E-04
  biological process    GO:0048634  regulation of muscle organ development                                                       104    6    0.48    12.6    7.84E-06   2.00E-04
  biological process    GO:0090316  positive regulation of intracellular protein transport                                        88    6     0.4    14.89   2.96E-06   2.00E-04
  biological process    GO:0032989  cellular component morphogenesis                                                             1000   16   4.58    3.49    8.23E-06   2.00E-04
  biological process    GO:0048729  tissue morphogenesis                                                                         472    11   2.16    5.09    8.81E-06   2.00E-04
  biological process    GO:0048869  cellular developmental process                                                               2829   29   12.96   2.24    6.09E-06   2.00E-04
  biological process    GO:0051222  positive regulation of protein transport                                                     163    7    0.75    9.38    9.29E-06   2.00E-04
  biological process    GO:0001658  branching involved in ureteric bud morphogenesis                                              64    5    0.29    17.06   1.07E-05   2.00E-04
  biological process    GO:0061138  morphogenesis of a branching epithelium                                                      169    7    0.77    9.04    1.18E-05   2.00E-04
  biological process    GO:0009887  organ morphogenesis                                                                          802    15   3.67    4.08    2.53E-06   2.00E-04
  biological process    GO:0090092  regulation of transmembrane receptor protein serine/threonine kinase signaling pathway       168    7    0.77     9.1    1.13E-05   2.00E-04
  biological process    GO:0045598  regulation of fat cell differentiation                                                        64    5    0.29    17.06   1.07E-05   2.00E-04
  biological process    GO:0016202  regulation of striated muscle tissue development                                             102    6    0.47    12.84   7.01E-06   2.00E-04
  biological process    GO:0060485  mesenchyme development                                                                       162    7    0.74    9.44    8.93E-06   2.00E-04
  biological process    GO:0042476  odontogenesis                                                                                103    6    0.47    12.72   7.41E-06   2.00E-04
  biological process    GO:0035239  tube morphogenesis                                                                           300    9    1.37    6.55    8.57E-06   2.00E-04
  biological process    GO:0022612  gland morphogenesis                                                                          110    6     0.5    11.91   1.08E-05   2.00E-04
  biological process    GO:0048732  gland development                                                                            277    9    1.27    7.09    4.49E-06   2.00E-04
  biological process    GO:0048762  mesenchymal cell differentiation                                                             141    7    0.65    10.84   3.57E-06   2.00E-04
  biological process    GO:0032388  positive regulation of intracellular transport                                                95    6    0.44    13.79   4.64E-06   2.00E-04
  biological process    GO:0002009  morphogenesis of an epithelium                                                               370    10   1.69     5.9    6.51E-06   2.00E-04
  biological process    GO:2000027  regulation of organ morphogenesis                                                            147    7    0.67    10.4    4.71E-06   2.00E-04
  biological process    GO:0034330  cell junction organization                                                                   195    8    0.89    8.96    2.87E-06   2.00E-04
  biological process    GO:0051153  regulation of striated muscle cell differentiation                                            64    5    0.29    17.06   1.07E-05   2.00E-04
  biological process    GO:0042307  positive regulation of protein import into nucleus                                            61    5    0.28    17.9    8.45E-06   2.00E-04
  biological process    GO:0045662  negative regulation of myoblast differentiation                                               10    3    0.05    65.51   1.08E-05   2.00E-04
  biological process    GO:0001763  morphogenesis of a branching structure                                                       196    8     0.9    8.91    2.98E-06   2.00E-04
  biological process    GO:0000902  cell morphogenesis                                                                           945    16   4.33     3.7    4.00E-06   2.00E-04
  biological process    GO:0048646  anatomical structure formation involved in morphogenesis                                     1594   21    7.3    2.88    4.88E-06   2.00E-04
  biological process    GO:0000904  cell morphogenesis involved in differentiation                                               704    13   3.22    4.03    1.52E-05   3.00E-04
  biological process    GO:0060284  regulation of cell development                                                               495    11   2.27    4.85    1.38E-05   3.00E-04
  biological process    GO:1901213  regulation of transcription from RNA polymerase II promoter involved in heart development     12    3    0.05    54.59   1.96E-05   3.00E-04
  molecular function    GO:0008013  beta-catenin binding                                                                          63    5    0.28    18.1    8.03E-06   6.00E-04
  cellular component    GO:0005913  cell-cell adherens junction                                                                   46    4    0.19    21.18   3.73E-05   3.30E-03
  cellular component    GO:0070161  anchoring junction                                                                           218    6    0.89     6.7    3.00E-04   8.80E-03
  cellular component    GO:0005912  adherens junction                                                                            201    6    0.83    7.27    2.00E-04   8.80E-03

C, the number of reference genes in the category; O, the number of genes in the gene set and also in the category; E, expected number in the category; R, the ratio of enrichment, rawP, the p value from hypergeometric test; adjP, the p value adjusted by the multiple test adjustment.

[^1]: These authors contributed equally to this work.
